Towards elimination: measles susceptivility in Australia and 17 European countries
- 1 March 2008
- journal article
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 86 (3) , 197-204
- https://doi.org/10.2471/blt.07.041129
Abstract
To evaluate age-specific measles susceptibility in Australia and 17 European countries. As part of the European Sero-Epidemiology Network 2 (ESEN2), 18 countries collected large national serum banks between 1996 and 2004. These banks were tested for measles IgG and the results converted to a common unitage to enable valid intercountry comparisons. Historical vaccination and disease incidence data were also collected. Age-stratified population susceptibility levels were compared to WHO European Region targets for measles elimination of < 15% in those aged 2–4 years, < 10% in 5–9-year-olds and < 5% in older age groups. Seven countries (Czech Republic, Hungary, Luxembourg, Spain, Slovakia, Slovenia and Sweden) met or came very close to the elimination targets. Four countries (Australia, Israel, Lithuania and Malta) had susceptibility levels above WHO targets in some older age groups indicating possible gaps in protection. Seven countries (Belgium, Bulgaria, Cyprus, England and Wales, Ireland, Latvia and Romania) were deemed to be at risk of epidemics as a result of high susceptibility in children and also, in some cases, adults. Although all countries now implement a two-dose measles vaccination schedule, if the WHO European Region target of measles elimination by 2010 is to be achieved higher routine coverage as well as vaccination campaigns in some older age cohorts are needed in some countries. Without these improvements, continued measles transmission and outbreaks are expected in Europe.Keywords
This publication has 21 references indexed in Scilit:
- Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and AustraliaEpidemiology and Infection, 2007
- Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st centuryEpidemiology and Infection, 2006
- The MMR vaccination and autism controversy in United Kingdom 1998–2005: Inevitable community outrage or a failure of risk communication?Vaccine, 2006
- Assessment of measles incidence, measles-related complications and hospitalisations during an outbreak in a southern Italian regionVaccine, 2006
- Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunityVaccine, 2004
- Persistence of Vaccine-Induced Antibody to Measles 26–33 Years after VaccinationThe Journal of Infectious Diseases, 2004
- The Theory of Measles Elimination: Implications for the Design of Elimination StrategiesThe Journal of Infectious Diseases, 2004
- The Elimination of Indigenous Measles Transmission in England and WalesThe Journal of Infectious Diseases, 2003
- Immunogenicity of second dose measles–mumps–rubella (MMR) vaccine and implications for serosurveillanceVaccine, 2002
- The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubellaEpidemiology and Infection, 2000